Polymorphisms in MGP gene and their association with lead toxicity

Toxicology Mechanisms and Methods

Volumn 19, Issue 3, 2009, Pages 209-213

  Shaik, Abjal Pasha ^a   Jamil, Kaiser ^b  

^a Indo American Cancer Institute and Research Centre   (India)

^b Bhagwan Mahavir Medical Research Centre   (India)

Author keywords

Blood lead levels; Lead toxicity; MGP gene polymorphisms; PCR

Indexed keywords

HEMOGLOBIN; LEAD; MATRIX GAMMA CARBOXY GLUTAMIC ACID PROTEIN; PROTEIN DERIVATIVE; UNCLASSIFIED DRUG;

ADULT; ALLELE; ARTICLE; BATTERY INDUSTRY; CONTROLLED STUDY; FEMALE; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENOTYPE; HEMOGLOBIN BLOOD LEVEL; HUMAN; HUMAN EXPERIMENT; LEAD BLOOD LEVEL; LEAD POISONING; LEUKOCYTE COUNT; MALE; MATRIX GAMMA CARBOXY GLUTAMIC ACID PROTEIN GENE; NORMAL HUMAN; POLYMERASE CHAIN REACTION; POTENTIOMETRY; PRIORITY JOURNAL; RESTRICTION FRAGMENT; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; THROMBOCYTE COUNT;

ADOLESCENT; ADULT; BASE SEQUENCE; CALCIUM-BINDING PROTEINS; DNA PRIMERS; EXTRACELLULAR MATRIX PROTEINS; FEMALE; GENOTYPE; HEMOGLOBINS; HUMANS; LEAD; MALE; MIDDLE AGED; POLYMERASE CHAIN REACTION; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; POLYMORPHISM, SINGLE NUCLEOTIDE; YOUNG ADULT;

EID: 68949142040     PISSN: 15376516     EISSN: 15376524     Source Type: Journal    
DOI: 10.1080/15376510802488181     Document Type: Article

References (25)

1. Afshin, F., Davies J.D., Braam, L.A., Spronk, H.M., Proudfoot, D., Chan, S., O'Shaughnessy, K.M., Weissberg, P.L., Vermeer, C. and Shanahan C.M. 2001. A polymorphism of the human matrix γ-carboxyglutamic acid protein promoter alters binding of an activating protein-1 complex and is associated with altered transcription and serum levels. J. Biol. Chem. 276:32466-32473.
2. Astrin, K. H., Bishop, D. F., Wetmur, J. G., Kaul, B. C., Davidow, B. and Desnick, R. J. 1987. Aminolevulinic acid dehydratase isozymes and lead toxicity. Ann. N.Y. Acad. Sci. 514:23-29.
3. ATSDR, Agency for Toxic Substances and Disease Registry. 1998. Toxicological profile for lead (update), U.S. Department of Health and Human Services, pp. 45-268.
4. Bergdahl, I. A. 1998. Lead-binding proteins-a way to understand lead toxicity? Metals and Biomolecules. Analysis Magazine, EDP Sciences; Wiley-VCH.
5. Bressler, J. P. and Goldstein, G. W. 1991. Mechanisms of lead toxicity. Biochem. Pharmacol. 41:479-484.
6. Cancela, L., Hsieh, C. L., Franke, U. Price P. A. 1990. Molecular structure chromosomal assignment, and promoter organization of the human matrix Gla protein gene. J. Biol. Chem. 265:15040-15048.
7. Cardon, L. R. and Bell, J. I. 2001. Association study designs for complex diseases. Nature Rev. Genet. 2:91-99.
8. Ellenhorn, M. J. 1997. Lead. In: Medical toxicology: Diagnosis and treatment of human poisoning. Metals and related compounds, 2nd ed., Williams and Wilkins, Baltimore, MD, pp. 1563-1579.
9. Fu, H. and Boffetta, P. 1995. Cancer and occupational exposure to inorganic lead compounds: a meta-analysis of published data. Occup. Environ. Med. 52:73-81.
10. Goyer, R. A. 2001. Lead. In: Bingham, E., Cohrssen, B. and Powell, C. H. (Eds.), Patty's toxicology, 5th ed, John Wiley & Sons, Inc., New York, pp. 611-675.
11. Luo, G., Ducy, P., McKee, M. D., Pinero, G. J., Loyer, E., Behringer, R. R. and Karsenty, G. 1997. Spontaneous calcification of arteries and cartilage in mice lacking matrix Gla protein. Nature 386:78-81.
12. Mahaffey, K. R. 1995. Nutrition and lead: strategies for public health. Environ. Health Perspect. 103:191-196.
13. NTP. 2003. Report on carcinogens background document for lead and lead compounds. National Toxicology.
14. Onalaja, A. O. and Claudio, L. 2000. Genetic susceptibility to lead poisoning. Environ. Health Perspect. 108(Suppl 1):23-28.
15. Price P. A., Gethin, T. R., Pardini, A. W., Caputo, W. F., Williamson, J. M., Matthew, K. 2002. Discovery of a high molecular weight complex of calcium, phosphate, fetuin, and matrixcarboxyglutamic acid protein in the serum of etidronate-treated rats. J. Biol. Chem. 277:3926-3934.
16. Price, P. A. and Williamson, M. K. 1985. Primary structure of bovine matrix Gla protein, a new vitamin K-dependent bone protein. J. Biol. Chem. 260:14971-14975.
17. Price, P. A., Faus, S. A. and Williamson, M. K. 2000. Warfarin-induced artery calcification is accelerated by growth and vitamin D. Arterioscler. Thromb. Vasc. Biol. 20:317-327.
18. Price, P. A., Urist, M. R. and Otawara, Y. 1983. Matrix Gla protein, a new gammacarboxyglutamic acid-containing protein which is associated with the organic matrix of bone. Biochem. Biophys. Res. Commun. 117:765-771.
19. Rezende, V. B., Barbosa, F. Jr., Montenegro, M. F., Sandrim, V. C., Gerlach, R. F. and Tanus-Santos, J. E. 2008. Haplotypes of vitamin D receptor modulate the circulating levels of lead in exposed subjects. Arch. Toxicol. 82:29-36.
20. Shaik, A. P., Sankar, S., Reddy, S. C., Das, P. G. and Jamil, K. 2006. Lead-induced genotoxicity in lymphocytes from peripheral blood samples of humans: in vitro studies. Drug Chem. Toxicol. 1:1-14.
21. Shanahan, C. M., Proudfoot, D., Farzaneh-Far, A. and Weissberg, P. L. 1998. The role of Gla proteins in vascular calcification. Crit. Rev. Eukaryot. Gene Express. 8:357-375.
22. Speer, M. Y. and Giachelli, C. M. 2004. Regulation of cardiovascular calcification. Cardiovasc. Pathol. 13:63-70.
23. Steenland, K. P. and Boffetta, P. 2000. Lead and cancer in humans: where are we now? Am. J. Ind. Med. 38:295-299.
24. Zar, J. H. 1996. Biostatistical analysis, Prentice Hall, New Jersey.
25. Zhang, W., Leng, S., Dai, Y. and Wang, Y. 2003. Study on association polymorphism of MGP(T-138C) gene and blood lead level in children. Wei Sheng Yan Jiu 32:514-515.